BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 3, 2016
View Archived Issues
Vaxil Bio completes reverse takeover transaction
Read More
Microbion and Haisco enter agreement to develop and commercialize MBN-101
Read More
Onxeo acquires DNA Therapeutics, provides update on Validive development plan
Read More
CAMH and Impel NeuroPharma sign licensing agreement for neuropeptide treatment for depression
Read More
Anti-sclerostin antibody from Mereo granted U.S. orphan status for osteogenesis imperfecta
Read More
CSIR reports development of anticancer agents
Read More
Oxalate descarboxylase receives FDA orphan drug designation for pediatric hyperoxaluria
Read More
Alkem Laboratories discloses cathepsin K inhibitors
Read More
Clinical candidate GDC-0326 identified from novel, selective PI3Kalpha inhibitors
Read More
Amgen files for FDA approval of Blincyto for pediatric Ph-negative B-cell precursor ALL
Read More
GlycoMimetics announces initial clinical data from phase I trial of GMI-1271 in AML
Read More
EyeGate receives additional milestone payment for the development of EGP-437
Read More
Baxalta submits MAA for Adynovi for the treatment of hemophilia A
Read More
Nuvo Research completes reorganization
Read More
Merck Patent and Cancer Research Technology describe CDK8/cyclin C inhibitors
Read More
Johns Hopkins University patent reveals UAP inhibitors
Read More
Arromax Pharmatech divulges protein kinase inhibitors
Read More
Ixodes in SPA agreement with FDA on phase III trial of Ixogel to prevent Lyme disease
Read More
GEFs as strong prognostic markers of cancer progression
Read More
DDIT4 gene is a marker for outcomes in multiple cancer types
Read More
Otonomy launches Otiprio in U.S.
Read More
TiGenix seeks European approval for Cx-601
Read More
Phase II trial of danegaptide for cardiac reperfusion injuries does not meet primary endpoint
Read More
Interim data from phase IIb trial of VT-1161 in onychomycosis
Read More
C4X Discovery acquires Adorial and its subsidiaries
Read More
Genetic variability of SCN4A is associated with essential tremor
Read More
Cynata Therapeutics enters preliminary agreement for strategic alliance with Regience in Japan
Read More
Voclosporin receives FDA fast track designation for the treatment of lupus nephritis
Read More